Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harriet Corvol

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Pharmacogenomics|May 10, 2008
Pharmacogenetic response to albuterol among asthmaticsHarriet Corvol, Esteban González Burchard
Current Opinion in Gastroenterology|December 27, 2018
Modifier genes in cystic fibrosis-related liver diseaseDominique Debray, Harriet Corvol, Chantal Housset
Frontiers in Pharmacology|October 24, 2018
Emerging microRNA Therapeutic Approaches for Cystic FibrosisPauline Bardin, Florence Sonneville, Harriet Corvol, et al.
BMJ Case Reports|May 3, 2014
An idiopathic congenital chylothorax: surgery or conservative management?Caroline Perisson, Nadia Nathan, Michele Larroquet, et al.
BMJ Case Reports|February 20, 2024
Disseminated tuberculosis in a migrant childVictorine Boccard, Fany Corvol, Blandine Prévost, et al.
Cells|November 27, 2021
TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic FibrosisChristie Mitri, Himanshu Sharma, Harriet Corvol, et al.
Paediatric Respiratory Reviews|June 2, 2015
Biomarkers in Interstitial lung diseasesNadia Nathan, Harriet Corvol, Serge Amselem, et al.
International Journal of Molecular Sciences|November 26, 2022
Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier GenesJulie Mésinèle, Manon Ruffin, Loïc Guillot, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 18, 2019
Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severityAlekh Paranjapye, Manon Ruffin, Ann Harris, et al.
BMJ Case Reports|November 13, 2012
A rare CFTR intronic mutation related to a mild CF disease in a 12-year-old girlNadia Nathan, Emmanuelle Girodon, Annick Clement, et al.
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Pharmacogenomics|May 10, 2008
Pharmacogenetic response to albuterol among asthmaticsHarriet Corvol, Esteban González Burchard
Current Opinion in Gastroenterology|December 27, 2018
Modifier genes in cystic fibrosis-related liver diseaseDominique Debray, Harriet Corvol, Chantal Housset
Frontiers in Pharmacology|October 24, 2018
Emerging microRNA Therapeutic Approaches for Cystic FibrosisPauline Bardin, Florence Sonneville, Harriet Corvol, et al.
BMJ Case Reports|May 3, 2014
An idiopathic congenital chylothorax: surgery or conservative management?Caroline Perisson, Nadia Nathan, Michele Larroquet, et al.
BMJ Case Reports|February 20, 2024
Disseminated tuberculosis in a migrant childVictorine Boccard, Fany Corvol, Blandine Prévost, et al.
Cells|November 27, 2021
TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic FibrosisChristie Mitri, Himanshu Sharma, Harriet Corvol, et al.
Paediatric Respiratory Reviews|June 2, 2015
Biomarkers in Interstitial lung diseasesNadia Nathan, Harriet Corvol, Serge Amselem, et al.
International Journal of Molecular Sciences|November 26, 2022
Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier GenesJulie Mésinèle, Manon Ruffin, Loïc Guillot, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 18, 2019
Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severityAlekh Paranjapye, Manon Ruffin, Ann Harris, et al.
BMJ Case Reports|November 13, 2012
A rare CFTR intronic mutation related to a mild CF disease in a 12-year-old girlNadia Nathan, Emmanuelle Girodon, Annick Clement, et al.
Pageof 15